MeiraGTx rises after deal with Hologen to form joint venture [Seeking Alpha]
MeiraGTx Reports Fourth Quarter and Full Year 2024 Financial and Operational Results and Recent Business Updates
MeiraGTx Enters into a Strategic Collaboration with Hologen AI to Expedite Phase 3 Development of AAV-GAD for Parkinson’s Disease and Industrialize MeiraGTx’s Proprietary Manufacturing Process
Forbes Daily: Automakers Get Coveted Carveout Amid Tariff Escalation [Forbes]
This Founder’s Gene Therapy Company Helped Blind Kids See Again [Forbes]